QCL partnered with McKinley Building Corporation in April 2020 to double operational facilities with phased openings and full completion in early 2024. The new 110,000 sq. ft. industrial structure offers a wide range of features, including over 15,000 sq.ft. of ISO 7 and 8 modular clean room space, two robotic aseptic filling lines within ISO 5 isolators, a WFI / pure steam generation system, and 7,000 sq. ft of supporting analytical laboratories. All of these features expand QCL’s capabilities into sterile fill and finish manufacturing of injectable drugs.
